Related Experiment Video
Updated: Mar 26, 2026
06:34
The Caco-2 Cell Bioassay for Measurement of Food Iron Bioavailability
Published on: April 28, 2022
6.0K
Research progress on berberine with a special focus on its oral bioavailability
Chang-Shun Liu1, Yu-Rong Zheng1, Ying-Feng Zhang1
1Guangdong Pharmaceutical University, Guangzhou, Guangdong Province 510006, China.
Fitoterapia
|February 7, 2016
Summary
Berberine (BBR) shows promise for metabolic disorders and cancer, but its effectiveness is limited by poor oral bioavailability. Strategies to enhance BBR absorption and reduce first-pass metabolism are crucial for clinical applications.
Area of Science:
- Pharmacology
- Drug Delivery
- Natural Products
Background:
- Berberine (BBR) is a natural product with potential therapeutic applications in diabetes, hyperlipidemia, and cancer.
- Poor oral bioavailability significantly hinders the clinical utility of BBR.
Purpose of the Study:
- To review the pharmacological activities of BBR.
- To analyze factors contributing to BBR's low oral bioavailability.
- To discuss strategies for improving BBR oral bioavailability for new indications.
Main Methods:
- Literature review of pharmacological activities of BBR.
- Analysis of pharmacokinetic characteristics influencing BBR absorption.
- Discussion of formulation strategies to overcome bioavailability challenges.
Main Results:
- BBR exhibits significant therapeutic potential for metabolic disorders and cancer.
- Key challenges for BBR oral delivery include poor absorption and extensive first-pass metabolism.
- Understanding pharmacokinetics is essential for developing effective BBR formulations.
Conclusions:
- Berberine is a promising candidate for treating metabolic diseases and cancer.
- Improving oral bioavailability is critical for realizing BBR's full therapeutic potential.
- Further research into formulation and delivery systems is needed to overcome BBR's pharmacokinetic limitations.
Keywords:
AbsorptionBerberineFirst-pass effectOral bioavailabilityPharmacokineticsPharmacological activitiesMore Related Videos
14:54An In Vivo Method for Evaluating the Gut-Blood Barrier and Liver Metabolism of Microbiota Products
Published on: October 20, 2018
9.0K
08:28Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
Published on: December 14, 2021
10.6K
Related Concept Videos
01:13Bioavailability: Overview
5.0K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
5.0K
01:17Bioavailability: Overview
661
Bioavailability refers to the proportion of an administered drug that reaches the systemic circulation in its active, unaltered form. It is a crucial pharmacokinetic parameter that determines the effectiveness of a drug in achieving its intended therapeutic outcomes. The route of administration significantly influences bioavailability, with intravenous administration achieving 100% bioavailability as the drug directly enters the bloodstream. In contrast, oral administration often results in...
661
01:24Factors Influencing Drug Absorption: Presystemic Elimination
1.1K
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
1.1K
01:22Bioavailability: Influencing Factors
567
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
567
01:23Factors Influencing Bioavailability: First-Pass Elimination
8.5K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
8.5K
01:30Modified-Release Drug Delivery Systems: Bioavailability
105
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
105